SANGAMO THERAPEUTICS, INC. (SGMOQ) Free cash flow 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$97.3MFY2025 · since FY2016: -$66.6M → -$97.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.3M | -44.4% |
| FY2024 | -$67.4M | +72.6% |
| FY2023 | -$246.0M | -0.9% |
| FY2022 | -$243.8M | +5.0% |
| FY2021 | -$256.5M | -265.3% |
| FY2020 | $155.2M | +194.0% |
| FY2019 | -$165.1M | -2433.8% |
| FY2018 | -$6.5M | -187.7% |
| FY2017 | $7.4M | +111.2% |
| FY2016 | -$66.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice